Generic placeholder image

Current Traditional Medicine

Author(s): Lav Singh, Arpit Singh, Divyanshu yadav, Apurv Chhavi, Ravi Prakash Srivastava, Shivaraman Pandey, Pooja Dixit, Ramakant, Praveen Chandra Verma and Gauri Saxena*

DOI: 10.2174/2215083808666220806113243

DownloadDownload PDF Flyer Cite As
Overview of COVID-19 Pandemic: Its Management and Prevention in Light of the Indian Traditional Medicine System

Article ID: e060822207331 Pages: 8

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

With the global death toll nearing 3.3 million, India being amongst the top 4 countries, the condition is more than fearsome. World Health Organization (WHO) recommends one doctor per 1000 population ratio, but India lags it by one doctor to 1456 people, which sets a lot of pressure on the healthcare system. Traditional remedies are becoming increasingly popular in India as a result of the lack of a proper medical system. Due to the rich diversity of medicinal herbs and drugs, India has been managing health issues with its 5000 years old medication system. Amidst all this, the traditional medicine system has given relief to plenty of diseases and remains the primary defence system against COVID-19. Therefore, COVID-19 is also managed by its different medicinal systems, which are collectively known as the AYUSH regime. It had been a recognized system to tackle diseases in the past. In this mini-review, we performed a deep study of the Indian traditional medicine system in managing the COVID-19 situation.

Keywords: COVID-19, AYUSH, traditional medicines, pandemic, Ayurveda, medicinal plant.

Graphical Abstract

[1]
Worldometer. 2022. Available from: https://www.worldometers. info/coronavirus/
[2]
Andrews MA, Areekal B, Rajesh KR, et al. First confirmed case of COVID-19 infection in India: A case report. Indian J Med Res 2020; 151(5): 490-2.
[http://dx.doi.org/10.4103/ijmr.IJMR_2131_20] [PMID: 32611918]
[3]
Government of India. Available from: www.ayush.gov.in/ayush-guidelines.html
[4]
Hussain W, Haleem KS, Khan I, et al. Medicinal plants: A repository of antiviral metabolites. Future Virol 2017; 12(6): 299-308.
[http://dx.doi.org/10.2217/fvl-2016-0110]
[5]
Kurokawa M, Shimizu T, Watanabe W, Shiraki K. Development of new antiviral agents from natural products. Open Antimicrob Agents J 2010; 2(1): 49-57.
[6]
Ang L, Song E, Lee HW, Lee MS. Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials. J Clin Med 2020; 9(5): 1583.
[http://dx.doi.org/10.3390/jcm9051583] [PMID: 32456123]
[7]
Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 2007; 74(2): 92-101.
[http://dx.doi.org/10.1016/j.antiviral.2006.04.014] [PMID: 16730806]
[8]
Rastogi S, Pandey DN, Singh RH. COVID-19 pandemic: A pragmatic plan for Ayurveda intervention. J Ayurveda Integr Med 2022; 13(1): 100312.
[PMID: 32382220]
[9]
Devpura G, Tomar BS, Nathiya D, et al. Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients. Phytomedicine 2021; 84: 153494.
[http://dx.doi.org/10.1016/j.phymed.2021.153494] [PMID: 33596494]
[10]
Huang KL, Lai YK, Lin CC, Chang JM. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. World J Gastroenterol 2006; 12(35): 5721-5.
[http://dx.doi.org/10.3748/wjg.v12.i35.5721] [PMID: 17007029]
[11]
Asres K, Bucar F. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle. Ethiop Med J 2005; 43(1): 15-20.
[PMID: 16370525]
[12]
Lubbe A, Seibert I, Klimkait T, van der Kooy F. Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 2012; 141(3): 854-9.
[http://dx.doi.org/10.1016/j.jep.2012.03.024] [PMID: 22465592]
[13]
Sassi AB, Harzallah-Skhiri F, Bourgougnon N, Aouni M. Antiviral activity of some Tunisian medicinal plants against Herpes simplex virus type 1. Nat Prod Res 2008; 22(1): 53-65.
[http://dx.doi.org/10.1080/14786410701589790] [PMID: 17999339]
[14]
Jahan I, Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk J Biol 2020; 44(3): 228-41.
[http://dx.doi.org/10.3906/biy-2005-114] [PMID: 32595359]
[15]
Goyal M. Strategies and avenues for COVID-19 - Ayurveda perception. Ayu 2019; 40(3): 139-40.
[http://dx.doi.org/10.4103/ayu.AYU_226_20] [PMID: 33281388]
[16]
Pandkar PD, Sachdeva V. Pathophysiology of COVID-19 and Host centric approaches of Ayurveda. J Ayurveda Integr Med 2022; 13(1): 100380.
[PMID: 33519134]
[17]
Publicity Department of the People’s Republic of China. Available from: www.Nhc.Gov
[18]
Eda N, Shimizu K, Suzuki S, Tanabe Y, Lee E, Akama T. Effects of yoga exercise on salivary beta-defensin 2. Eur J Appl Physiol 2013; 113(10): 2621-7.
[http://dx.doi.org/10.1007/s00421-013-2703-y] [PMID: 23925803]
[19]
Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet 1990; 335(8702): 1381-3.
[http://dx.doi.org/10.1016/0140-6736(90)91254-8] [PMID: 1971670]
[20]
Meera S, Vandana Rani M, Sreedhar C, Robin DT. A review on the therapeutic effects of NetiKriya with special reference to JalaNeti. J Ayurveda Integr Med 2020; 11(2): 185-9.
[http://dx.doi.org/10.1016/j.jaim.2018.06.006] [PMID: 30616871]
[21]
Ayush Gov. Revised guidelines for homeopathy practitioners for home isolated COVID-19 patient Available from: https://www. ayush.gov.in/docs/CCRH Revised Guidelines for Homeopathy Practitioners for Home Isolated COVID 19 patient-f.pdf
[22]
Nikhat S, Fazil M. Overview of COVID-19; its prevention and management in the light of Unani medicine. Sci Total Environ 2020; 728: 138859.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138859] [PMID: 32334163]
[23]
Alam MA, Gani MA, Shama G, Sofi G, Quamri MA. Possible role of Unani Pharmacology in COVID-19 - a narrative review. Rev Environ Health 2020; 36(3): 391-6.
[http://dx.doi.org/10.1515/reveh-2020-0106] [PMID: 33155997]
[24]
Home HD. Available from: http://homeo.delhigovt.nic.in/wps/wcm/connect/doit-homeopathy/Homeopathy/Home
[25]
PIB India PRID=1600940. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1600940
[26]
PIB India PRID 1609523. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1609523
[27]
Priya R, Sujatha V. AYUSH for COVID-19: Science or Superstition? Indian J Public Health 2020; 64(6) (Suppl.): S105-7.
[http://dx.doi.org/10.4103/ijph.IJPH_500_20] [PMID: 32496237]
[28]
MoAGoI Notification. Ministry of AYUSH Notification to be published in the Extraordinary Gazette of India, No L11011/8/2020/AS. New Delhi: Ministry of AYUSH, Government of India 2020.
[29]
Tillu G, Chaturvedi S, Chopra A, Patwardhan B. Public health approach of Ayurveda and yoga for COVID-19 prophylaxis. J Altern Complement Med 2020; 26(5): 360-4.
[http://dx.doi.org/10.1089/acm.2020.0129] [PMID: 32310670]
[30]
Alam S, Sarker MMR, Afrin S, et al. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: Update on clinical trials and mechanism of actions. Front Pharmacol 2021; 12: 671498.
[http://dx.doi.org/10.3389/fphar.2021.671498] [PMID: 34122096]
[31]
Asili P, Mirahmad M, Tabatabaei-Malazy O, et al. Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review. Daru 2021; 29(2): 449-67.
[http://dx.doi.org/10.1007/s40199-021-00422-8] [PMID: 34762250]
[32]
Montealegre-Gómez G, Garavito E, Gómez-López A, Rojas-Villarraga A, Parra-Medina R. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatol Clin 2021; 17(7): 371-5.
[http://dx.doi.org/10.1016/j.reumae.2020.05.008] [PMID: 34301378]
[33]
Schlesinger N, Firestein BL, Brunetti L. Colchicine in COVID-19: An old drug, new use. Curr Pharmacol Rep 2020; 6(4): 1-9.
[http://dx.doi.org/10.1007/s40495-020-00225-6] [PMID: 32837853]
[34]
NCT04322682. Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19) ClinicalTrialsGov. 2020. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04322682
[35]
Derosa G, Maffioli P, D’Angelo A, Di Pierro F. A role for quercetin in coronavirus disease 2019 (COVID-19). Phytother Res 2021; 35(3): 1230-6.
[http://dx.doi.org/10.1002/ptr.6887] [PMID: 33034398]
[36]
NCT04377789. Effect of quercetin on prophylaxis and treatment of COVID-19 ClinicalTrialsgov NCT04377789. 2020. Available from: https://www.clinicaltrials.gov/ct2/show
[37]
Protecting health care workers during the covid-19 outbreak. NCT04387643. 2020. Available from: https://www.clinicaltrials. gov/ct2/show/
[38]
NCT04480398. Efficacy and safety of guduchi ghan vati for covid-19 asymptomatic patients. 2020. Available from: https://www. clinicaltrials.gov/ct2/show/
[39]
Kumar A, Prasad G, Srivastav S, Gautam VK, Sharma N. A Retrospective study on efficacy and safety of Guduchi Ghan Vati for COVID-19 asymptomatic patients. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.07.23.20160424]
[40]
National Formulary of Unani Medicine. CCRUM, Ministry of Health and Family welfare. Govt of India: New Delhi 1993; 167(224): 110-215.
[41]
Ministry of AYUSH. Govt of India. D.O.No.S.16030/18/2019-Nam 6th march 2020. Available from: https://www.ayush.gov.in/docs/125.pdf
[42]
Chaturvedi S, Kumar N, Tillu G, Deshpande S, Patwardhan B. AYUSH, modern medicine and the COVID-19 pandemic. Indian J Med Ethics 2020; 5(3): 1-4.
[http://dx.doi.org/10.20529/IJME.2020.058] [PMID: 32546457]
[43]
Ahmad S, Zahiruddin S, Parveen B, et al. Indian medicinal plants and formulations and their potential against COVID-19–preclinical and clinical research. Front Pharmacol 2021; 11: 578970.
[http://dx.doi.org/10.3389/fphar.2020.578970] [PMID: 33737875]
[44]
Pandey MM, Rastogi S, Rawat AK. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med 2013; 2013: 376327.
[http://dx.doi.org/10.1155/2013/376327] [PMID: 23864888]
[45]
Anand S, Raman D, Shetty D, Joshi D, Hamsaveni CG, Unnikrishnan DC. Antibiotic prescription practices for surgical prophylaxis in India: An observational study. Am J Trop Med Hyg 2019; 101(4): 919-22.
[http://dx.doi.org/10.4269/ajtmh.19-0267] [PMID: 31407655]
[46]
Ministry of AYUSH. Ayurveda’s Immunity Boosting Measures for Self-Care during COVID 19 Crisis. 2020. Available from: https://www.mohfw.gov.in/pdf/ImmunityBoostingAYUSHAdvisory.pdf
[47]
Maurya DK, Sharma D. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach. J Biomol Struct Dyn 2020; 1-16.
[http://dx.doi.org/10.1080/07391102.2020.1852119] [PMID: 33251972]
[48]
Kishor RS, Rajendra BM, Ramhari BM, Siddheshwar SS. Review paper on Ayush system of medicine against COVID-19. Res J Pharmacog Phytochem 2021; 13(2): 103-6.
[49]
Pushpendra K, Garud A, Tomar V, Solanki SS, Garud N. Analgesic effect of herbal preparation Rasnasaptakkadha. Indian J Nat Prod 2009; 25(4): 11-4.
[50]
Thakur K, Mol PM, Gawhankar M, Gupta H, Patil P, Thakur M. Physicochemical characterization and antimicrobial properties of Mahamanjishthadikadhafi: An Ayurvedic formulation. Ann Phytomed 2020; 9(1): 78-90.
[http://dx.doi.org/10.21276/ap.2020.9.1.9]
[51]
Sheth PA, Pawar AT, Mote CS, More C. Antianemic activity of polyherbal formulation, Raktavardhak Kadha, against phenylhydrazine-induced anemia in rats. J Ayurveda Integr Med 2021; 12(2): 340-5.
[http://dx.doi.org/10.1016/j.jaim.2021.02.009] [PMID: 34016498]
[52]
Nesari TM, Bhardwaj A, ShriKrishna R, et al. Neem (Azadirachta indica A. Juss) capsules for prophylaxis of COVID-19 infection: A pilot, double-blind, randomized controlled trial. Altern Ther Health Med 2021; 23: 1-8.
[53]
Ganeshan S. Traditional oral care medicinal plants survey of Tamil Nadu. Nat Prod Rad 2008; 7: 166-72.
[54]
Carounanidy U, Satyanarayanan R, Velmurugan A. Use of an aqueous extract of Terminalia chebula as an anticaries agent: A clinical study. Indian J Dent Res 2007; 18(4): 152-6.
[http://dx.doi.org/10.4103/0970-9290.35823] [PMID: 17938489]
[55]
Rao S, Dinkar C, Vaishnav LK, et al. The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: An investigational study. Integr Cancer Ther 2014; 13(3): 201-10.
[http://dx.doi.org/10.1177/1534735413503549] [PMID: 24165896]
[56]
Jain K, Jadhav M, Dand N. Herbal eugenol. BVCOP J Pharm Res 2017.
[57]
Agnihotri A, Kaur A, Arora R. Oral ulceration and Indian herbs: A scoping review. Dent J Adv Stud 2020; 8(3): 71-9.
[http://dx.doi.org/10.1055/s-0040-1716316]
[58]
Tangade PS, Mathur A, Tirth A, Kabasi S. Anti-gingivitis effects of Acacia arabica-containing toothpaste. Chin J Dent Res 2012; 15(1): 49-53.
[PMID: 22866283]
[59]
Jain S, Tandon PN. Ayurvedic medicine and Indian literature on epilepsy. Neurol Asia 2004; 9(1): 57-8.
[60]
Priya BK, Elansekaran S, Ramamurthy M, Srinivasan V, Kanniyakumari M, Christian GJ. A review on siddha external therapy–nasiyam (Nasal Instillation). Int J Ayurveda Pharma Res 2018; 6(10): 47-53.
[61]
Rajkumar RP. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet. Brain Behav Immun 2020; 87: 8-9.
[http://dx.doi.org/10.1016/j.bbi.2020.04.056] [PMID: 32334064]
[62]
Babar RP, Gund SM, Kale AB. Concept of medicated ghee (ghrita kalpana) in the management of childhood epilepsy (apasmara). 2017. Available from: www.ayurpub.com
[63]
Porte SM. Ayurvedic aspect of rabies and its management. Ayushdhara. Int J Res AYUSH Allied Systems 2015; 2(2): 86-93.
[64]
Fahmy UAL, Alaofi A, Awan ZA, Alqarni HM, Alhakamy NA. Optimization of thymoquinone-loaded coconut oil nanostructured lipid carriers for the management of ethanol-induced ulcer. AAPS PharmSciTech 2020; 21: 1-0.
[65]
Ramesh SV. Coconut oil as a virucidal agent: Prospects and challenges in COVID-19. Authorea Preprints 2020.
[http://dx.doi.org/10.22541/au.158888265.53194913]
[66]
Ajoodanian N, Hosseini MB, Valizadeh S, Assadollahi M. Effect of massage therapy on physiologic response in premature infants with respiratory distress syndrome treated with Nasal Continuous Positive Airway Pressure (NCPAP). Med J Tabriz Univ Med Sci Health Serv 2013; 34(6): 7-12.
[67]
Sadlon AE, Lamson DW. Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern Med Rev 2010; 15(1): 33-47.
[PMID: 20359267]
[68]
Boyd EM, Sheppard EP. The effect of steam inhalation of volatile oils on the output and composition of respiratory tract fluid. J Pharmacol Exp Ther 1968; 163(1): 250-6.
[PMID: 5673712]
[69]
Burrow A, Eccles R, Jones AS. The effects of camphor, eucalyptus and menthol vapour on nasal resistance to airflow and nasal sensation. Acta Otolaryngol 1983; 96(1-2): 157-61.
[http://dx.doi.org/10.3109/00016488309132886] [PMID: 6613544]
[70]
Eccles R, Jones AS. The effect of menthol on nasal resistance to air flow. J Laryngol Otol 1983; 97(8): 705-9.
[http://dx.doi.org/10.1017/S002221510009486X] [PMID: 6886530]
[71]
Horváth G, Ács K. Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti-inflammatory action: A review. Flavour Fragrance J 2015; 30(5): 331-41.
[http://dx.doi.org/10.1002/ffj.3252] [PMID: 32313366]
[72]
Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan SA, Anwar F. Essential oils used in aromatherapy: A systemic review. Asian Pac J Trop Biomed 2015; 5(8): 601-11.
[http://dx.doi.org/10.1016/j.apjtb.2015.05.007]
[73]
Venkatachalam SR, Chattopadhyay S. Natural radioprotective agents: An overview. Curr Org Chem 2005; 9(4): 389-404.
[http://dx.doi.org/10.2174/1385272053174930]
[74]
Kumar D, Arya V, Kaur R, Bhat ZA, Gupta VK, Kumar V. A review of immunomodulators in the Indian traditional health care system. J Microbiol Immunol Infect 2012; 45(3): 165-84.
[http://dx.doi.org/10.1016/j.jmii.2011.09.030] [PMID: 22154993]
[75]
Agarwal SS, Singh VK. Immunomodulators: A review of studies on Indian medicinal plants and synthetic peptides. Part-I: Medicinal plants. Proc Indian Natl Sci Acad B Biol Sci 1999; 65(3-4): 179-204.
[76]
Nidhi P, Swati P, Krishnamurthy R. Indian Tinospora species: Natural immunomodulators and therapeutic agents. Int J Pharm Biol Chem Sci 2013; 2(2): 1-9.
[77]
Sharma P, Kumar P, Sharma R, Gupta G, Chaudhary A. Immunomodulators: Role of medicinal plants in immune system. Natl J Physiol Pharm Pharmacol 2017; 7(6): 552.
[http://dx.doi.org/10.5455/njppp.2017.7.0203808032017]
[78]
Bhat H, Sampath P, Pai R, Bollor R, Baliga M, Fayad R. Indian medicinal plants as immunomodulators: Scientific validation of the ethnomedicinal beliefs. In: Watson RR, Preedy VR, Eds. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Cambridge, Massachusetts: Academic Press 2012; 22: pp. 215-24.
[79]
Zaigham M, Hamiduddin M, Ikram M. Aslussoos (Glycyrrhiza glabra Linn): A root with immense pharmaceutical potential and its utilization in Unani system of medicine. IJHM 2019; 7(5): 27-34.
[80]
Farzana MU, Sultana A. Prevention and management of covid-19 with Unani medicine. Sch Int J Tradit Complement Med 2021; 4(1): 1-10.
[http://dx.doi.org/10.36348/sijtcm.2021.v04i01.001]
[81]
Prajapati M, Jayswal S, Maitreya BB. Phytochemical screening and comparative study of antioxidant activity of Cuminum cyminum L. and Nigella sativa L. IJSRR 2019; 8(2): 1356-64.
[82]
Sumathi S, Swathi K, Suganya K, et al. A broad perspective on COVID-19: A global pandemic and a focus on preventive medicine. Tradit Med Res 2021; 6(2): 12.
[http://dx.doi.org/10.53388/TMR20201018202]
[83]
Umashankar V, Deshpande SH, Hegde HV, Singh I, Chattopadhyay D. Phytochemical moieties from Indian traditional medicine for targeting dual hotspots on SARS-CoV-2 spike protein: An integrative in-silico approach. Front Med (Lausanne) 2021; 8: 672629.
[http://dx.doi.org/10.3389/fmed.2021.672629] [PMID: 34026798]
[84]
Singh PA, Bajwa N, Baldi A. Possible role of traditional systems of medicine to manage COVID-19: A review. Isr J Plant Sci 2021; 1: 1-26.
[85]
Saravanan J, Devasia N, Gopalasatheeskumar K, Sanish Devan V, Thanga Kokila K, Sanjay M. Anti-inflammatory, antipyretic and antibacterial study of Kabasura kudineer choornam. Int J Curr Adv Res 2018; 7(2): 9992e7.
[86]
Lee HJ, Hyun EA, Yoon WJ, et al. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 2006; 103(2): 208-16.
[http://dx.doi.org/10.1016/j.jep.2005.08.009] [PMID: 16182479]
[87]
Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M. Camphor (Cinnamomum camphora), a traditional remedy with the history of treating several diseases. Int J Case Rep Imag 2013; 4(2): 86-9.
[http://dx.doi.org/10.5348/ijcri-2013-02-267-RA-1]
[88]
Singh P, Srivastava B, Kumar A, Dubey NK. Fungal contamination of raw materials of some herbal drugs and recommendation of Cinnamomum camphora oil as herbal fungitoxicant. Microb Ecol 2008; 56(3): 555-60.
[http://dx.doi.org/10.1007/s00248-008-9375-x] [PMID: 18322727]
[89]
Christian JG, Meenakumari R, Rajamaheswari K, Sekaran P, Gajalakshmi G, Anand T. Phytochemical Screening of Adathodai Kudineer a Siddha Herbal concoction and Evaluation of its binding affinity with SARS-CoV-2 spike protein and ACE2 receptor spike protein complex through molecular docking in silico approach. Int J Ayurveda Med 2021; 12(2): 366-74.
[90]
Malabadi RB, Kolkar KP, Meti NT, Chalannavar RK. Camphor tree, Cinnamomum camphora (L.); Ethnobotany and pharmacological updates. Biomedicine (Taipei) 2021; 41(2): 181-4.
[http://dx.doi.org/10.51248/.v41i2.779]
[91]
Gautam AK, Pathak N, Ahamad T, et al. Pandemic in India: Special reference to Covid-19 and its technological aspect. J Stat Manage Syst 2021; 24(2): 387-410.